News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ISS Recommends BioSante Pharmaceuticals, Inc. (BPAX) Merger With ANI Pharmaceuticals, Inc.


2/26/2013 10:18:20 AM

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that ISS PROXY ADVISORY SERVICES, an independent proxy advisory firm, has recommended that BioSante stockholders vote “FOR” the adoption of the merger agreement between BioSante and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. at BioSante’s upcoming special meeting of stockholders scheduled to be held on March 15, 2013. In recommending that the merger transaction be approved, ISS noted, “(T)hus, in light of the reasonable strategic rationale for the merger and the potential value received by BioSante shareholders, support for this merger is warranted.”*

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES